| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |